Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan-Yuan Zhang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 16, 2025
Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancerLina Chen, Xiu-Hao Zhang, Zi-Ji Mao, et al.
JTO Clinical and Research Reports|December 17, 2021
Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the <i>EGFR</i> L858R Mutation: A Brief ReportYu-Qing Chen, Yu-Fa Li, Chan-Yuan Zhang, et al.
Cancer Treatment and Research Communications|April 30, 2023
Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangementQing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, et al.
Clinical Lung Cancer|December 25, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System DiseaseChang Lu, Hong-Hong Yan, Chan-Yuan Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2022
A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survivalChan-Yuan Zhang, Hao Sun, Jun-Wei Su, et al.
Journal of Thoracic Disease|October 23, 2023
Expression of <i>EGFR</i>-mutant proteins and genomic evolution in <i>EGFR</i>-mutant transformed small cell lung cancerShi-Ling Zhang, Chan-Yuan Zhang, Yu-Qing Chen, et al.
Cell Reports. Medicine|January 19, 2023
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world studyHan-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lung Cancer (Amsterdam, Netherlands)|August 16, 2025
Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancerLina Chen, Xiu-Hao Zhang, Zi-Ji Mao, et al.
JTO Clinical and Research Reports|December 17, 2021
Response to Icotinib Plus Chemotherapy in Pulmonary Atypical Carcinoid Harboring the <i>EGFR</i> L858R Mutation: A Brief ReportYu-Qing Chen, Yu-Fa Li, Chan-Yuan Zhang, et al.
Cancer Treatment and Research Communications|April 30, 2023
Pathological characteristics and tumour immune microenvironment of lung malignancies with RET rearrangementQing-Yun Gao, Fa-Man Xiao, Xiao-Cheng Lin, et al.
Clinical Lung Cancer|December 25, 2024
PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged NSCLC and Central Nervous System DiseaseChang Lu, Hong-Hong Yan, Chan-Yuan Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2022
A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survivalChan-Yuan Zhang, Hao Sun, Jun-Wei Su, et al.
Journal of Thoracic Disease|October 23, 2023
Expression of <i>EGFR</i>-mutant proteins and genomic evolution in <i>EGFR</i>-mutant transformed small cell lung cancerShi-Ling Zhang, Chan-Yuan Zhang, Yu-Qing Chen, et al.
Cell Reports. Medicine|January 19, 2023
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world studyHan-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, et al.
Pageof 1